Medicare Enrolled
Dr. George Stoupakis, MD
Cardiovascular Disease · Hackensack, NJ
Practice pattern: Electrophysiology & Device
— Practice focused on heart rhythm disorders and cardiac device management
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Stoupakis from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Stoupakis?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Stoupakis
Dr. George Stoupakis is a cardiovascular disease specialist in Hackensack, NJ, with 20 years of NPI registration. Based on federal Medicare data, Dr. Stoupakis performed 5,463 Medicare services across 3,164 unique beneficiaries.
Between the years covered by Open Payments, Dr. Stoupakis received a total of $6,747 from 41 pharmaceutical and/or device companies across 332 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Stoupakis is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 12% volume in NJ
$6,747 industry payments
Medicare Practice Summary
Medicare Utilization ↗5,463
Medicare services
Top 12% in NJ for cardiovascular disease
3,164
Unique beneficiaries
$64
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~273 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| ECG, 1-3 leads with physician review A simple electrocardiogram recording using one to three leads. A physician reviews the results. |
1,028 | $6 | $8 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
793 | $67 | $91 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
663 | $11 | $18 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
648 | $72 | $105 |
| EKG interpretation and report A standard electrocardiogram test that records the heart's electrical activity using at least 12 leads. The service includes a professional interpretation of the results and a written report. |
433 | $7 | $30 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
297 | $167 | $240 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
205 | $101 | $127 |
| Complete ultrasound of retroperitoneum An ultrasound examination of the structures located behind the abdominal cavity. |
164 | $97 | $124 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
162 | $165 | $221 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
159 | $112 | $156 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
154 | $54 | $71 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
110 | $51 | $287 |
| Ultrasound of leg arteries or grafts An imaging test that uses sound waves to create pictures of the blood vessels in the legs or any surgical grafts present. |
71 | $223 | $278 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
66 | $90 | $149 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while an electrocardiogram is monitored under physician supervision. |
53 | $18 | $30 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram, with physician review of the results. |
53 | $12 | $20 |
| 2-day continuous ECG with review and report A two-day continuous electrocardiogram recording that includes a professional review and written report of the results. |
51 | $55 | $83 |
| Continuous ECG monitoring, up to 30 days Continuous heart rhythm monitoring for up to 30 days, including professional review and reporting of the results. |
50 | $19 | $27 |
| Continuous external EKG monitoring, 48 hours to 7 days This procedure involves recording, analyzing, and interpreting a continuous external electrocardiogram (EKG) over a period of more than 48 hours up to 7 days. |
46 | $246 | $307 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
45 | $65 | $80 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
45 | $30 | $38 |
| 30-day continuous ECG with patient-triggered event transmission and review This procedure involves continuous electrocardiogram monitoring for up to 30 days, including the transmission of patient-triggered events. A healthcare professional reviews the data and provides a report. |
33 | $774 | $982 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
32 | $145 | $184 |
| Continuous external EKG monitoring, 1 week Recording, analysis, and interpretation of a continuous external electrocardiogram performed over a period of more than one week. |
22 | $260 | $324 |
| Follow-up heart ultrasound An ultrasound of the heart performed to monitor or reassess a previously identified condition or treatment progress. |
21 | $20 | $85 |
| Cardiac catheterization | 15 | $221 | $364 |
| Emergency department visit, moderate complexity An emergency department visit for an established or new patient involving a moderate level of medical decision making. |
15 | $102 | $127 |
| Emergency department visit, high complexity An emergency department visit involving a high level of medical decision making. |
15 | $148 | $184 |
| Transitional care management services, moderate complexity Services provided to coordinate care during the transition from an inpatient or other facility setting back to the community. This includes follow-up and management of a health problem of at least moderate complexity. |
14 | $116 | $149 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
5.7% high complexity
12.4% medium
81.9% routine
Industry Payment Transparency
Open Payments through 2024 ↗$6,747
Total received (2018-2024)
Avg $964/year across 7 years
Top 29% in NJ for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
41
Companies
332
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,402 (94.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$346 (5.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,147
2023
$981
2022
$1,188
2021
$1,068
2020
$391
2019
$752
2018
$1,221
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ShockWave Medical, Inc
$224
CVRx, Inc.
$208
AstraZeneca Pharmaceuticals LP
$195
Novartis Pharmaceuticals Corporation
$177
ABIOMED
$89
HEARTFLOW, INC.
$76
Amgen Inc.
$48
Merck Sharp & Dohme LLC
$35
Boston Scientific Corporation
$23
Esperion Therapeutics, Inc.
$19
Boehringer Ingelheim Pharmaceuticals, Inc.
$18
PFIZER INC.
$18
Lexicon Pharmaceuticals, Inc.
$17
Top 3 companies account for 54.7% of 2024 payments
All-time payments by company (2018-2024) ›
ABIOMED
$936
Novartis Pharmaceuticals Corporation
$904
AstraZeneca Pharmaceuticals LP
$610
CVRx, Inc.
$486
Janssen Pharmaceuticals, Inc
$384
Amgen Inc.
$366
Penumbra, Inc.
$359
ShockWave Medical, Inc
$263
Amarin Pharma Inc.
$255
Boston Scientific Corporation
$236
ARBOR PHARMACEUTICALS, INC.
$173
E.R. Squibb & Sons, L.L.C.
$146
Merck Sharp & Dohme LLC
$145
Boehringer Ingelheim Pharmaceuticals, Inc.
$138
Cardiovascular Systems Inc.
$130
Edwards Lifesciences Corporation
$119
Abbott Laboratories
$101
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$98
PFIZER INC.
$98
Bayer HealthCare Pharmaceuticals Inc.
$95
HEARTFLOW, INC.
$76
Gilead Sciences, Inc.
$70
SANOFI-AVENTIS U.S. LLC
$65
Esperion Therapeutics, Inc.
$62
Lexicon Pharmaceuticals, Inc.
$56
HeartFlow, Inc.
$49
BOSTON SCIENTIFIC CORPORATION
$43
Merck Sharp & Dohme Corporation
$42
Regeneron Healthcare Solutions, Inc.
$38
Bardy Diagnostics, Inc.
$35
Medtronic Vascular, Inc.
$28
Silk Road Medical, Inc.
$23
Azurity Pharmaceuticals, Inc.
$16
ARALEZ PHARMACEUTICALS US INC.
$14
Alnylam Pharmaceuticals Inc.
$13
Allergan Inc.
$13
Amryt Pharma Holdings Ltd
$13
Terumo Medical Corporation
$13
Kiniksa Pharmaceuticals, Ltd.
$13
ATRICURE, INC.
$12
Lundbeck LLC
$11
Top 3 companies account for 36.3% of all-time payments
Associated products mentioned in payments ›
ANDEXXA · ATRICLIP LAA EXCLUSION SYSTEM · Adempas · Arcalyst · BRILINTA · BYSTOLIC · Barostim Neo System · CAMZYOS · Carnation Ambulatory Monitor · Corlanor · Diamondback Coronary · ELIQUIS · ENROUTE Transcarotid Neuroprotection System · ENTRESTO · EVKEEZA · Edarbi · Edarbyclor · FARXIGA · FASENRA · FFRct · HeartMate · Impella · Indigo System · Inpefa · JARDIANCE · JUXTAPID · Kerendia · LEQVIO · LOKELMA · LifeVest · MITRACLIP · MitraClip System · NEXLETOL · NORTHERA · ONPATTRO · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · RESONATE · Ranexa · Repatha · Reveal LINQ · SAPIEN 3 Ultra RESILIA · SHOCKWAVE IVL SYSTEM WITH THE SHOCKWAVE C2 CORONARY IVL CATHETER · SYNERGY · Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter · THORATEC HEARTMATE 3 LVAS IMPLANT KIT · TR Band · VERQUVO · VYNDAQEL · Vascepa · WAINUA · WATCHMAN · WATCHMAN Access System · WATCHMAN FLX · XARELTO · ZONTIVITY
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (95%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Cardiologists within 10 mi
1,872
Per 100K population
196.1
County median income
$123,715
Nearest hospital
HACKENSACK UNIVERSITY MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Stoupakis is an electrophysiology & device specialist, with above-average Medicare volume (top 12% in NJ), with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Stoupakis experienced with ecg, 1-3 leads with physician review?
Based on Medicare claims data, Dr. Stoupakis performed 1,028 ecg, 1-3 leads with physician review services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Stoupakis receive payments from pharmaceutical companies?
Yes. Dr. Stoupakis received a total of $6,747 from 41 companies across 332 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Stoupakis's costs compare to other cardiologists in Hackensack?
Dr. Stoupakis's average Medicare payment per service is $64. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Stoupakis) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in Hackensack
Browse cardiologists in Hackensack ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in NJ
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in NJ
Which NJ cardiologists receive the most from drug and device companies.
By company
ABIOMED Payments to Doctors
See all physicians who received payments from ABIOMED.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology